TY - JOUR
T1 - The metabolic axis of macrophage and immune cell polarization
AU - Hobson-Gutierrez, Spencer A.
AU - Carmona-Fontaine, Carlos
N1 - Funding Information:
The authors’ work is supported by the National Cancer Institute of NIH (R00CA191021) and the Center for Genomics and Systems Biology at New York University.
Publisher Copyright:
© 2018. Published by The Company of Biologists Ltd.
PY - 2018/8
Y1 - 2018/8
N2 - The extracellular space of solid tumors ranges from being well-nurtured to being completely ischemic and can serve as a source of intratumoral heterogeneity, determining the behavior and molecular profiles of malignant and stromal cells. Here, we discuss how the metabolic tumor microenvironment modulates the phenotypes of the immune cells that infiltrate tumors, with an emphasis on tumor-associated macrophages. These cells constitute a diverse population that has pro-tumoral and antiinflammatory properties, and are likened to anti-inflammatory 'M2' macrophages. Recent findings show how different metabolic microenvironments specify an array of phenotypic changes in macrophages. In tumors, extracellular metabolite levels vary predictably according to proximity to the vasculature, and phenotypic changes in tumor-associated macrophages and in other immune cells are also predictable. We speculate that this 'metabolic axis' of macrophage polarization modulates-and is modulated by-the response to inflammatory cues, creating a wide variety of possible phenotypic states. Understanding how extracellular metabolites influence cell phenotypes allows us to predict how tumor-associated macrophages and other tumor cells might change, with the aim of harnessing this predictability for therapy. Overall, we describe an emerging picture in which chemokines, growth factors and the metabolic tumor microenvironment act together to determine the phenotypes of tumor-infiltrating immune cells.
AB - The extracellular space of solid tumors ranges from being well-nurtured to being completely ischemic and can serve as a source of intratumoral heterogeneity, determining the behavior and molecular profiles of malignant and stromal cells. Here, we discuss how the metabolic tumor microenvironment modulates the phenotypes of the immune cells that infiltrate tumors, with an emphasis on tumor-associated macrophages. These cells constitute a diverse population that has pro-tumoral and antiinflammatory properties, and are likened to anti-inflammatory 'M2' macrophages. Recent findings show how different metabolic microenvironments specify an array of phenotypic changes in macrophages. In tumors, extracellular metabolite levels vary predictably according to proximity to the vasculature, and phenotypic changes in tumor-associated macrophages and in other immune cells are also predictable. We speculate that this 'metabolic axis' of macrophage polarization modulates-and is modulated by-the response to inflammatory cues, creating a wide variety of possible phenotypic states. Understanding how extracellular metabolites influence cell phenotypes allows us to predict how tumor-associated macrophages and other tumor cells might change, with the aim of harnessing this predictability for therapy. Overall, we describe an emerging picture in which chemokines, growth factors and the metabolic tumor microenvironment act together to determine the phenotypes of tumor-infiltrating immune cells.
KW - Cancer metabolism
KW - Immunometabolism
KW - Tumor microenvironment
UR - http://www.scopus.com/inward/record.url?scp=85053720730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053720730&partnerID=8YFLogxK
U2 - 10.1242/dmm.034462
DO - 10.1242/dmm.034462
M3 - Review article
C2 - 29991530
AN - SCOPUS:85053720730
SN - 1754-8403
VL - 11
JO - DMM Disease Models and Mechanisms
JF - DMM Disease Models and Mechanisms
IS - 8
M1 - dmm034462
ER -